Transcutaneous Auricular Vagal Nerve Stimulation Against Fatigue Syndrome in Patients with Long COVID: Results of the Randomized, Placebo-Controlled Clinical Pilot Trial COVIVA.

Gierthmuehlen M, Schmieder K, Thon N, Gierthmuehlen PC

Open source

DOI
10.1007/s40120-026-00928-w
Published
2026 Jun
Container
Neurology and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40120-026-00928-w,
  title = {Transcutaneous Auricular Vagal Nerve Stimulation Against Fatigue Syndrome in Patients with Long COVID: Results of the Randomized, Placebo-Controlled Clinical Pilot Trial COVIVA.},
  author = {Gierthmuehlen M and Schmieder K and Thon N and Gierthmuehlen PC},
  year = {2026},
  journal = {Neurology and therapy},
  doi = {10.1007/s40120-026-00928-w},
  url = {https://doi.org/10.1007/s40120-026-00928-w}
}

RIS

TY  - JOUR
TI  - Transcutaneous Auricular Vagal Nerve Stimulation Against Fatigue Syndrome in Patients with Long COVID: Results of the Randomized, Placebo-Controlled Clinical Pilot Trial COVIVA.
AU  - Gierthmuehlen M
AU  - Schmieder K
AU  - Thon N
AU  - Gierthmuehlen PC
PY  - 2026
JO  - Neurology and therapy
DO  - 10.1007/s40120-026-00928-w
UR  - https://doi.org/10.1007/s40120-026-00928-w
ER  - 

APA

M, G., K, S., N, T., & PC, G. (2026). Transcutaneous Auricular Vagal Nerve Stimulation Against Fatigue Syndrome in Patients with Long COVID: Results of the Randomized, Placebo-Controlled Clinical Pilot Trial COVIVA.. Neurology and therapy. https://doi.org/10.1007/s40120-026-00928-w

Source records